325
million
people affected worldwide by hepatitis in 2018
21
countries
account for 64% of the burden
7%
of 71 million people
with chronic hepatitis C have access to treatment
Country profiles
Select a country to see key HBV and HCV related data
Evidence base
The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews, guidelines, and policy documents. In response to identified global research priorities, the evidence based first looked at implementation of hepatitis B birth dose vaccination and global, regional, national, and sub-national action plans.
